Crossmark

TeleHCV: A single-visit protocol and minimal passive remote monitoring are sufficient to achieve high SVR with a sofosbuvir-velpatasvir regimen

Crossref DOI link: https://doi.org/10.1016/j.clinsp.2025.100643

Published Print: 2025-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Oliveira, Jerônimo De Conto https://orcid.org/0000-0001-8540-3068
Schacher, Fernando Comunello https://orcid.org/0000-0002-6991-1174
Costa, Marisa Boff https://orcid.org/0000-0003-2579-2545
Kolling, Maurício Godinho https://orcid.org/0009-0000-8150-8620
Costa, Raquel Boff https://orcid.org/0000-0002-1665-8208
Scherer, Henrique Cabral https://orcid.org/0000-0001-6620-0054
Fernandes, Paula Martins https://orcid.org/0000-0001-6823-1022
Katz, Natan https://orcid.org/0000-0002-0659-7747
Gonçalves, Marcelo Rodrigues https://orcid.org/0000-0001-8516-8547
Rados, Dimitris Varvaki https://orcid.org/0000-0003-0819-5343
Álvares-da-Silva, Mário Reis https://orcid.org/0000-0002-5001-246X
License Information

Text and Data Mining valid from 2025-01-01

Text and Data Mining valid from 2025-01-01

Version of Record valid from 2025-03-31
More Information

This article is maintained by: Elsevier

Article Title: TeleHCV: A single-visit protocol and minimal passive remote monitoring are sufficient to achieve high SVR with a sofosbuvir-velpatasvir regimen

Journal Title: Clinics

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.clinsp.2025.100643

Content Type: article

Copyright: © 2025 HCFMUSP. Published by Elsevier España, S.L.U.